Europe - Euronext Paris - EPA:SAN - FR0000120578 - Common Stock
Taking everything into account, SAN scores 4 out of 10 in our fundamental rating. SAN was compared to 55 industry peers in the Pharmaceuticals industry. SAN scores excellent on profitability, but there are concerns on its financial health. SAN is not valued too expensively and it also shows a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.63% | ||
| ROE | 18.84% | ||
| ROIC | 13.4% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.61% | ||
| PM (TTM) | 20.63% | ||
| GM | 72.29% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.3 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.51 | ||
| Fwd PE | 9.45 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.62 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 4 / 10 to SAN.PA.
ChartMill assigns a valuation rating of 5 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.
SANOFI (SAN.PA) has a profitability rating of 7 / 10.
The Price/Earnings (PE) ratio for SANOFI (SAN.PA) is 10.51 and the Price/Book (PB) ratio is 2.63.
The financial health rating of SANOFI (SAN.PA) is 3 / 10.